🔔 After the Bell
🎯 Session Review
Wednesday gave markets another green day, with the S&P 500 adding 0.38% to close at 7,572.40, the Nasdaq leading the pack with a 0.62% gain, and the Dow tacking on 150 points. The rally had some genuine fuel behind it, courtesy of a cooler-than-expected Producer Price Index reading. PPI dropped 0.3% in June after rising 0.6% in May, a number that had analysts doing a double take since they expected flat.That inflation data gave Treasury yields a little breathing room. The 10-year dipped to 4.55% and the 5-year slid to 4.26%, which loosened financial conditions just enough to keep buyers interested. A softer dollar, with the DXY falling to 100.51, added to the risk-on vibe sweeping through equities.
Earnings season is cranking up, and today's batch was a mixed bag. The stories ranged from record-breaking asset management to a bank that spooked its own investors. Buckle up, because the next few weeks are going to keep things lively.
📊 Today's Market Movers
|
▲ Gainers
|
▼ Losers
|
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🚀 Key Catalysts
BlackRock was the headline winner of the day, reporting assets under management hit a record 15 trillion dollars on the back of market gains and heavy ETF inflows. BLK beat profit estimates, and it is a reminder that when markets go up, the asset management business practically runs itself. This is the compounding flywheel in action.Citigroup (C) was the opposite story. Management blindsided investors by flagging higher expenses for the second half of the year, sending analysts scrambling to cut estimates and shares sliding hard. Meanwhile, United Airlines (UAL) beat second-quarter earnings estimates but flagged 6 billion dollars in fuel costs as jet fuel prices have crept higher again this month. UAL guided full-year adjusted EPS between 9 and 11 dollars, which is solid, but that fuel line item is a real weight on margins.
Novo Nordisk (NVO) grabbed attention after the European Commission approved its once-daily Wegovy pill for weight management, making it the first oral GLP-1 weight-loss treatment to clear that regulatory hurdle. That is a genuinely big deal for the obesity drug market and adds a new competitive dimension to a space that has been red hot.
AI Breakthrough Could Soon Reorder Stock Market Winners and Losers
🎭 Investor Mood
The tariff conversation is not going away quietly. A U.S. bill imposing sanctions on Russia has some Democratic lawmakers concerned because it could hand President Trump broader powers to impose trade measures. That kind of policy uncertainty tends to simmer in the background and surface as volatility when least expected.
On the tech side, the Amazon (AMZN) cloud leadership shuffle, with Dave Brown exiting after 18 years and being replaced by e-commerce veteran Dave Treadwell, raised eyebrows. Leadership transitions at major cloud divisions get scrutinized closely given how critical AWS is to the broader enterprise tech ecosystem. Investors will be watching for any signal that strategy or execution shifts.
🔍 5 Focus Points for Tomorrow
| 🌍 | Watch C shares for stabilization after the expense warning shock and analyst estimate cuts |
| 📊 | NVO oral Wegovy approval in Europe: track competitor response from Eli Lilly and others |
| ⛽ | UAL fuel cost trajectory: jet fuel prices are rising again, watch airline sector margins closely |
| 🏛️ | Treasury yields: 10-year at 4.55% after soft PPI, any further softness could accelerate the rally |
| 📋 | SPCX and the space sector: watch for signs that post-IPO investor fatigue is lifting or deepening |
Elon is hiding something massive in Fremont, California…
💸 Bottom Line
Looking ahead, the rhythm of earnings season will continue to set the tone. The Citigroup expense warning is a reminder that even when the macro backdrop cooperates, company-specific execution risk can blindside you. Keep a close eye on how other major banks frame their second-half cost outlooks when they report.The NVO Wegovy pill approval in Europe is worth tracking for competitive ripple effects. Any time a new format, in this case an oral pill versus injections, enters a blockbuster market, it reshapes the conversation around market share and patient adoption. Eli Lilly investors in particular should be paying attention.
Finally, the SpaceX IPO hangover is real. After the space sector surged in May following the record-breaking IPO, SPCX has slumped as investors enter what analysts are calling an investment coma. That pattern of post-IPO sector fatigue is a classic setup worth monitoring. If broader markets stay firm and inflation data continues to cooperate, that coma could lift faster than expected.
📰 Further Reading
AI isn't just writing emails and creating videos. It's being wired into the financial system itself… moving faster than anyone in the world can control. And every breakthrough pushes us closer to one thing: A fully digital, government-issued dollar. A CBDC. Once that switch flips, the rules change o...
Click to see more and claim your free guide ->The biggest market opportunities don't wait for headlines — by the time the news breaks, the real move is often over. That's why we do the work early, and right now we're watching three small-cap companies that align with conditions historically preceding major market attention in 2026.
Click here to claim your free report before the crowd catches on.Last week, the CEOs of Nvidia, Apple, SpaceX, BlackRock, Goldman Sachs, Visa, Boeing, and more boarded Air Force One with President Trump to visit China. A U.S.-China trade deal would ignite a Melt Up in U.S. stocks, sending the market into a frenzy.
Learn the exact moves one Florida millionaire says to make today – before this window closes.



